United States· US:61958-1401_169d8571-3b28-4b3b-8def-18316f1297f3
Tybost
A cobicistat product containing cobicistat, registered in United States by Gilead Sciences, Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cobicistat is registered in 9 of 19 countries.
Countries holding a registration under ATC V03AX03 (cobicistat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Cobicistat · ATC V03AX03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- COBICISTAT
- Manufacturer
- Gilead Sciences, Inc.
- Country
- United States (US)
- ATC code
- V03AX03
- ATC class
- Cobicistat
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1161958-1401-1
- ndc11619581401130 TABLET, FILM COATED in 1 BOTTLE (61958-1401-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
541 interactions on record for cobicistat.
Graded by severity as the source publishes them — 243 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cobicistat · interactions on record
541 records
- 243 severe
- 277 moderate
- 21 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cobicistat in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGenvoya 150 mg - 150 mg - 200 mg - 10 mgGilead Sciences Ireland UC
- CzechiaTYBOSTGilead Sciences Ireland UC, Carrigtohill
- SpainTYBOST 150mg comprimidos recubiertos con peliculaGilead Sciences Ireland Unlimited Company
- FinlandTybostGilead Sciences Ireland UC
- IrelandTybost 150 mg film-coated tabletsGilead Sciences Ireland UC
- NetherlandsTybost 150 mg filmomhulde tablettenGilead Sciences Ireland UC
- PolandTybostGilead Sciences Ireland UC
- SwedenTybost 150 mg Filmdragerad tablettGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tybost
- Liechtenstein · Tybost
- Norway · Tybost
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e17854a-1fca-477f-879a-84bd7cb4a5bc GET /v1/drugs/4e17854a-1fca-477f-879a-84bd7cb4a5bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "COBICISTAT",
"productndc": "61958-1401",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA203094",
"marketing_category": "NDA"
}See everything about cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.